Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Durect Corporation (DRRX)

« Back to company index

DRRX Chatter Timeline

Stock Ticker for DRRX

Most Active Tweeters for DRRX

UserTweets
@AmericanBanking 2
@insiderbuyings 1
@TranscriptDaily 1
@TickerReport 1
@ConsumerFeed 1

Recent Tweets for DRRX

WOWlNV @WOWlNV
RT @LlcBillionaire: $DRRX head and shoulders
June 17th 2019, 4:06am
DataTrials @DataTrials
$DRRX Phase 2 Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis… Estimate Pri… https://t.co/yyAGkMy9N7
June 16th 2019, 1:06pm
ConsumerFeed @ConsumerFeed
DURECT Director Jon Saxe Buys $13,750.00 in $DRRX https://t.co/G0aUF8jrJa
June 12th 2019, 3:06am
insiderbuyings @insiderbuyings
$DRRX new insider buying: 25000 shares. https://t.co/aC84iakDTU
June 11th 2019, 11:06pm
macondailynews @macondailynews
Insider Buying: DURECT Co. $DRRX Director Acquires 25,000 Shares of Stock https://t.co/ZAPu7SteZ7
June 11th 2019, 11:06pm
AmericanBanking @AmericanBanking
DURECT Co. $DRRX Director Purchases $13,750.00 in Stock https://t.co/X1JxzIIGvK #stocks
June 11th 2019, 11:06pm
InsiderAlertsIA @InsiderAlertsIA
$DRRX: New Insider Filing on Director JON S SAXE: https://t.co/2DJEjn4r90
June 11th 2019, 8:06pm
fintel_io @fintel_io
Insider SAXE JON S reports buying 25,000 shares of $DRRX for a total cost of $13,749.86 https://t.co/PAfBfY4fPF
June 11th 2019, 8:06pm
Allstocknews @Allstocknews
$DRRX ALERT: New DURECT Corporation SEC Filing From our Stock News Alerts App
June 11th 2019, 8:06pm
StockTexts @StockTexts
$DRRX DURECT Corporation SEC Filing: Form 4 https://t.co/EYEiUM0W0r
June 11th 2019, 8:06pm
TranscriptDaily @TranscriptDaily
DURECT Co. $DRRX Expected to Post Earnings of -$0.05 Per Share https://t.co/TxYadm0Xs4
June 9th 2019, 8:06pm
LlcBillionaire @LlcBillionaire
$DRRX head and shoulders
June 9th 2019, 6:06pm
stocknewstimes @stocknewstimes
DURECT Co. $DRRX Expected to Post Earnings of -$0.05 Per Share https://t.co/vH9JQSNWeK
June 5th 2019, 8:06am
SleekMoneycom @SleekMoneycom
DURECT Co. $DRRX Expected to Post Earnings of -$0.05 Per Share https://t.co/z6q3iEWWmo #investing
June 5th 2019, 8:06am
JackalTrading @JackalTrading
$DRRX looks ready to make some noise.
June 4th 2019, 11:06am
AmericanBanking @AmericanBanking
$4.05 Million in Sales Expected for DURECT Co. $DRRX This Quarter https://t.co/OSzysg10MR #stocks
June 4th 2019, 4:06am
TickerReport @TickerReport
DURECT Co. $DRRX Expected to Announce Quarterly Sales of $4.05 Million https://t.co/h6e1CSf7hX
June 4th 2019, 4:06am
LlcBillionaire @LlcBillionaire
$DRRX shall we head back up??
June 2nd 2019, 6:06pm
ConsumerFeed @ConsumerFeed
-$0.05 Earnings Per Share Expected for DURECT Co. $DRRX This Quarter https://t.co/2EKJGzGWVO
June 2nd 2019, 4:06am
AmericanBanking @AmericanBanking
Zacks: Analysts Anticipate DURECT Co. $DRRX to Announce -$0.05 EPS https://t.co/hBy7gXXBoE #stocks
June 2nd 2019, 4:06am
OlympiaReport @OlympiaReport
DURECT Co. $DRRX Director Jon S. Saxe Buys 30,000 Shares https://t.co/KXjuPdTtjt
May 31st 2019, 9:05am
ZolmaxNews @ZolmaxNews
DURECT Co. $DRRX Director Jon S. Saxe Purchases 30,000 Shares https://t.co/eUizhE7GcD
May 30th 2019, 9:05am
ChartMill @ChartMill
The technical rating of $DRRX is bad and it also does not present a quality setup at the moment.… https://t.co/IT6ikkgys0
May 29th 2019, 11:05am
WOWlNV @WOWlNV
RT @fintel_io: Insider SAXE JON S reports buying 30,000 shares of $DRRX for a total cost of $18,903.05 https://t.co/PAfBfY4fPF
May 29th 2019, 8:05am
WOWlNV @WOWlNV
RT @WKRBNews: Insider Buying: DURECT Co. $DRRX Director Buys 30,000 Shares of Stock https://t.co/Gb69qAqDAL #markets
May 29th 2019, 8:05am
WOWlNV @WOWlNV
RT @AmericanBanking: DURECT Co. $DRRX Director Purchases $18,900.00 in Stock https://t.co/Ufx86j2upC #stocks
May 29th 2019, 8:05am
WOWlNV @WOWlNV
RT @insiderbuyings: $DRRX new insider buying: 30000 shares. https://t.co/aC84iakDTU
May 29th 2019, 8:05am
WOWlNV @WOWlNV
RT @TheMarketsDaily: DURECT Co. $DRRX Director Jon S. Saxe Acquires 30,000 Shares https://t.co/U9UnG0CSn6
May 29th 2019, 8:05am
TheMarketsDaily @TheMarketsDaily
DURECT Co. $DRRX Director Jon S. Saxe Acquires 30,000 Shares https://t.co/U9UnG0CSn6
May 29th 2019, 7:05am
insiderbuyings @insiderbuyings
$DRRX new insider buying: 30000 shares. https://t.co/aC84iakDTU
May 28th 2019, 11:05pm
AmericanBanking @AmericanBanking
DURECT Co. $DRRX Director Purchases $18,900.00 in Stock https://t.co/Ufx86j2upC #stocks
May 28th 2019, 8:05pm
WKRBNews @WKRBNews
Insider Buying: DURECT Co. $DRRX Director Buys 30,000 Shares of Stock https://t.co/Gb69qAqDAL #markets
May 28th 2019, 8:05pm
InsiderAlertsIA @InsiderAlertsIA
$DRRX: New Insider Filing on Director JON S SAXE: https://t.co/FUC9GbrR8h
May 28th 2019, 8:05pm
fintel_io @fintel_io
Insider SAXE JON S reports buying 30,000 shares of $DRRX for a total cost of $18,903.05 https://t.co/PAfBfY4fPF
May 28th 2019, 7:05pm
confcalltran @confcalltran
Durect Corporation director just picked up 30,000 shares https://t.co/IGtxdVzrAk $DRRX
May 28th 2019, 7:05pm
3TriggersTrader @3TriggersTrader
$DRRX 6035.going.vertical-up.at-the-open
May 28th 2019, 7:05am
WOWlNV @WOWlNV
RT @LlcBillionaire: $DRRX Resistance from 20 and 50 MA
May 27th 2019, 7:05pm
LlcBillionaire @LlcBillionaire
$DRRX Resistance from 20 and 50 MA
May 27th 2019, 3:05pm
WOWlNV @WOWlNV
RT @AnalystsAnalyst: $DRRX Highly Compelling Initial Ph2a DUR-928 Alcoholic Hepatitis Data https://t.co/q0bSddtTn6 $DRRX #biotech #smallcap…
May 24th 2019, 6:05pm
AnalystsAnalyst @AnalystsAnalyst
$DRRX Highly Compelling Initial Ph2a DUR-928 Alcoholic Hepatitis Data https://t.co/q0bSddtTn6 $DRRX #biotech… https://t.co/NMD5gVKlmf
May 24th 2019, 9:05am
stocknewstimes @stocknewstimes
DURECT $DRRX Trading Down 16.7% https://t.co/rBUOLKRJSD
May 23rd 2019, 9:05pm
SleekMoneycom @SleekMoneycom
DURECT $DRRX Trading Down 16.7% https://t.co/yKudzkrlON #investing
May 23rd 2019, 9:05pm
WOWlNV @WOWlNV
RT @ZacksAwareness: $DRRX Highly Compelling Initial Ph2a DUR-928 Alcoholic Hepatitis Data https://t.co/NlUc4nlS4E $DRRX #biotech #smallcap…
May 23rd 2019, 7:05pm
WOWlNV @WOWlNV
RT @risk_averse_: $DRRX Highly Compelling Initial Ph2a DUR-928 Alcoholic Hepatitis Data https://t.co/iYeRGzb5zV $DRRX #biotech #smallcap ht…
May 23rd 2019, 7:05pm
WOWlNV @WOWlNV
RT @ContentCarnivor: $DRRX Highly Compelling Initial Ph2a DUR-928 Alcoholic Hepatitis Data https://t.co/xfaDKJjKJk $DRRX #biotech #smallcap…
May 23rd 2019, 7:05pm
ContentCarnivor @ContentCarnivor
$DRRX Highly Compelling Initial Ph2a DUR-928 Alcoholic Hepatitis Data https://t.co/xfaDKJjKJk $DRRX #biotech… https://t.co/VkYRQWV6pO
May 23rd 2019, 5:05pm
risk_averse_ @risk_averse_
$DRRX Highly Compelling Initial Ph2a DUR-928 Alcoholic Hepatitis Data https://t.co/iYeRGzb5zV $DRRX #biotech… https://t.co/mKtqUvfduG
May 23rd 2019, 3:05pm
ZacksAwareness @ZacksAwareness
$DRRX Highly Compelling Initial Ph2a DUR-928 Alcoholic Hepatitis Data https://t.co/NlUc4nlS4E $DRRX #biotech… https://t.co/trF338sWB5
May 23rd 2019, 9:05am
WOWlNV @WOWlNV
RT @ahighelevation: $DRRX Highly Compelling Initial Ph2a DUR-928 Alcoholic Hepatitis Data https://t.co/8grI0dqOmp $DRRX #biotech #smallcap…
May 23rd 2019, 9:05am
ahighelevation @ahighelevation
$DRRX Highly Compelling Initial Ph2a DUR-928 Alcoholic Hepatitis Data https://t.co/8grI0dqOmp $DRRX #biotech… https://t.co/Z7CummpRzR
May 23rd 2019, 5:05am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.